Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3881-3890 of 4090 results

Catalogue Number:

PX-TA1483

Category:

G

Proteo Genix logo

Spartalizumab Biosimilar – Anti-PDCD1/ PD1/ CD279 mAb – Research Grade

Target: PDCD1/ PD1/ CD279
Target Alias Name: Spartalizumab/NPVPDR001/NVS240118/PDR001/PDCD1/ PD1/ CD279/anti-PDCD1/ PD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1537

Category:

G

Proteo Genix logo

Spesolimab Biosimilar – Anti-IL36RN mAb – Research Grade

Target: IL36RN
Target Alias Name: Spesolimab/BI 655130/IL36RN/anti-IL36RN
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1144

Category:

G

Proteo Genix logo

Stamulumab Biosimilar – Anti-MSTN/ GDF-8 mAb – Research Grade

Target: MSTN/ GDF-8
Target Alias Name: Stamulumab/MYO-029/MSTN/ GDF-8/anti-MSTN/ GDF-8
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1966

Category:

G

Proteo Genix logo

Stapokibart Biosimilar – Anti-IL-4RA mAb – Research Grade

Target: IL-4RA
Target Alias Name: anti-IL-4RA/ IL-4-binding protein/ IL-4 receptor subunit alpha/ Soluble IL-4R-alpha/ IL4-BP/ IL4R/ IL-4R subunit alpha/ IL-4R-alpha/ CD124/ Interleukin-4 receptor subunit alpha/ IL4RA/ Soluble IL-4 receptor subunit alpha/ sIL4Ralpha/prot
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1913

Category:

G

Proteo Genix logo

STRO-001 Biosimilar – Anti-HLA-DR antigens-associated invariant chain mAb – Research Grade

Target: HLA-DR antigens-associated invariant chain
Target Alias Name: anti-HLA-DR antigens-associated invariant chain/HLA class II histocompatibility antigen gamma chain/CD74/CLIP/Ia antigen-associated invariant chain/DHLAG/Ii/SP7219
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1897

Category:

G

Proteo Genix logo

STT-5058 Biosimilar – Anti-APOC3 mAb – Research Grade

Target: APOC3
Target Alias Name: anti-APOC3/ Apolipoprotein C3/ Apo-CIII/ Apolipoprotein C-III/ ApoC-III/ARGX-116
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1885

Category:

G

Proteo Genix logo

Suciraslimab Biosimilar – Anti-CD22 mAb – Research Grade

Target: CD22
Target Alias Name: Suciraslimab//CD22/anti-CD22
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1717

Category:

G

Proteo Genix logo

Sudubrilimab Biosimilar – Anti-CD274 mAb – Research Grade

Target: CD274
Target Alias Name: Sudubrilimab/IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1/ PDL1/ PD-L1/ B7 HOMOLOG 1/ B7H1))/ MONOCLONAL ANTIBODY/CD274/anti-CD274
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1718

Category:

G

Proteo Genix logo

Sugemalimab Biosimilar – Anti-PDL1 mAb – Research Grade

Target: PDL1
Target Alias Name: Sugemalimab/ANTI-PD-L1 MONOCLONAL ANTIBODY CS1001/ WBP 3155/ IMMUNOGLOBULIN G4 (228-PROLINE) (ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1)) (HUMAN MONOCLONAL CS1001 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL CS1001 .LAMBDA.-CHAIN/ DIMER/PDL1/anti-PDL1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1099

Category:

G

Proteo Genix logo

Sulesomab Biosimilar – Anti-NCA-90 mAb – Research Grade

Target: NCA-90
Target Alias Name: Sulesomab/IMMU-MN3/Technetium (99mTc) sulesomab/LeukoScan/NCA-90/anti-NCA-90
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Fab'-G1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo